(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MYISA

This trademark appears in the official USPTO history.

Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.

CANCELLED SEC. 8 (6-YR)Type: WordOffice: United States

Quick snapshot

MYISA

ST13

US500000086961372

Class

5, 42, 44

Filing

86961372

Registration

5958455

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

CANCELLED SEC. 8 (6-YR)

Case type

Application and registration

Recorded events

42

Latest update

08/18/2026

Trademark type

Word

Nice classes

5, 42, 44

Filing date

04/01/2016

Registration date

01/14/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/24/2026

Last transaction

08/18/2026

Responsible office

United States Patent and Trademark Office

Status code

710

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

2333 CH, NL

Examiner

OESTREICHER, SALIMA PARMAR

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ISA Pharmaceuticals B.V.
ISA Pharmaceuticals B.V.

Representatives

Todd A. Denys Porzio, Bromberg & Newman, P.C.

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Customized pharmaceutical and medicinal preparationstumor neo-antigen derived immunotherapeutic formulations for the treatment of an individual patient

Class 42

Scientific and technological servicesresearch and design relating thereto in the biotechnologicalchemical and pharmaceutical field and in the field of immunotherapy; industrial analysisanalysis of the designmanufacturing and development of immunotherapy pharmaceuticals; research services in the field of pharmaceuticals; scientific research and development services in the biotechnologicalchemical and pharmaceutical field and in the field of immunotherapy

Class 44

Medical services in the biotechnological and pharmaceutical field and in the field of immunotherapy; medical counseling in the field of customized pharmaceutical and medicinal preparations; medical analyses services in the field of customized pharmaceutical and medicinal preparations; medical screening; dispensing of pharmaceutical and medicinal preparations; none of the foregoing services being provided for or in relation to the treatment of snoring or sleep disorders

Publications

History of USPTO decisions and trademark events.

42 publications found

C8..

CANCELLED SEC. 8 (6-YR)

07/24/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/14/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/14/2020

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

12/12/2019

IUCN

NOTICE OF ALLOWANCE CANCELLED

12/09/2019

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

12/09/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/05/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/05/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/20/2019

EX5G

SOU EXTENSION 5 GRANTED

04/19/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/19/2019

EXT5

SOU EXTENSION 5 FILED

04/15/2019

EEXT

SOU TEAS EXTENSION RECEIVED

04/15/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/03/2018

EX4G

SOU EXTENSION 4 GRANTED

11/01/2018

EXT4

SOU EXTENSION 4 FILED

11/01/2018

EEXT

SOU TEAS EXTENSION RECEIVED

11/01/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/15/2018

EX3G

SOU EXTENSION 3 GRANTED

06/13/2018

EXT3

SOU EXTENSION 3 FILED

06/13/2018

EEXT

SOU TEAS EXTENSION RECEIVED

06/13/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/22/2017

EX2G

SOU EXTENSION 2 GRANTED

11/20/2017

EXT2

SOU EXTENSION 2 FILED

11/20/2017

EEXT

SOU TEAS EXTENSION RECEIVED

11/20/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/11/2017

EX1G

SOU EXTENSION 1 GRANTED

02/09/2017

EXT1

SOU EXTENSION 1 FILED

02/09/2017

EEXT

SOU TEAS EXTENSION RECEIVED

02/09/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/19/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/13/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/18/2016

PUBO

PUBLISHED FOR OPPOSITION

10/18/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/28/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/08/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

09/08/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/08/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

09/08/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/08/2016

DOCK

ASSIGNED TO EXAMINER

07/15/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/06/2016

NWAP

NEW APPLICATION ENTERED

04/05/2016

Continuous trademark protection

Get notified about every new filing that threatens MYISA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.